Waltham Massachusetts based Axial Biotherapeutics is raising $8,000,000.00 in New Debt Financing.
Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, Axial Biotherapeutics is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Donabedian played a…